UMIN ID: UMIN000002076
Registered date:14/06/2009
Aripiprazole research over schizophrenia patients (both on first episode and recurrence) about its efficacy and influence on cognitive function
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | schizophrenia |
| Date of first enrollment | 2009/06/01 |
| Target sample size | 20 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Monotherapy of aripiprazole: Estimate 8 weeks after the beginning, then follow up until 24 weeks (till 31/Mar/2012). About the dosage of aripiprazole, start at 6-12mg/day, then maintain at 6-30mg/day. |
Outcome(s)
| Primary Outcome | apply neuropsychological tasks and evaluate the difference of the score |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | 65years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | patients using epinephrine patients with allergic reaction to aripiprazole before diabetic patients and patients who have history of suffering from diabetes patients with (or, with the possibility of) pregnancy patients taking other antipsychotics other patients not suitable for this study |
Related Information
| Primary Sponsor | Kyoto University Hospital |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Scholarship department of neuropsychiatry |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| Affiliation | Kyoto University Hospital Department of Neuropsychiatry |
| scientific contact | |
| Name | Toshiya Murai |
| Address | 54 Shogoin-Kawahara-cho Sakyo-ku Kyoto Japan |
| Telephone | |
| Affiliation | Kyoto University Hospital Department of Neuropsychiatry |